Abstract:The aberrant expression of Matrix Metalloproteinases (MMPs) is known to contribute to the pathogenesis of airway remodeling and alveolar disruption in chronic obstructive pulmonary diseases (COPD). This study explored the relationship between MMP genetic variants and the risk of COPD in family and population based studies. For the discovery stages, eleven COPD patients from five families were subjected to whole genome sequencing (WGS), and 21 common mutations in MMPs and TIMPs were identified. Of these mutations, two SNPs rs2664370 and rs2664369 in MMP16 remained significant differences (P < 0.0024 and P < 0.0024, respectively). In subsequent verification studies, the mutations were genotyped by SNPscan technology in 590 unrelated patients and 594 controls. Functionally, we found that MMP16 expression significantly increased in COPD patients and Cigarette Smoke Extract (CSE) treated 16HBE cells compared to controls. This was also confirmed by bioinformatic analysis. COPD subjects carrying rs2664370C alleles showed decreased levels of MMP16 in the plasma and PBMCs compared to those carrying CT and TT alleles. Treatment with hsa-miR-576-5p mimics led to a greater reduction in luciferase reporter activity in cells co-transfected with rs2664370CC. In addition, Base Excess (BE), PCO2 and PO2 levels in rs2664370CC were significantly lower than rs2664370CT+TT (P < 0.001, P = 0.019, and P = 0.026, respectively). Taken together, this demonstrates that the rs2664370T>C variant decreases the risk of COPD likely thorough increasing the interaction with hsa-miR-576-5p and reducing the expression of MMP16. Therefore, common mutations in MMP16 reduce COPD risk and improve plasma blood gas levels.Funding Statement: This work was supported by grants from the National Natural Science Foundation of China (81520108001, 81700043, 81770043, and 81220108001), Guangdong Natural Science Foundation (2016A030313593), Guangzhou Science and Technology Programs for Science Study (201607020030), the National Key R&D Project (2016YFC 0903700), the 973 Key Scheme of China (2015CB553406), Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2014, for WL), Guangdong Province Universities and Colleges Key Grant for Innovative Research (cxzd1142), Guangzhou Department of Education (1201620007, 13C08, and 12A001S), Open Project of State Key Laboratory of Respiratory Disease (SKLRD-OP-201808, SKLRD-QN-201719), Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program (2017BT01S155), and the National Key R&D Program of China (2018YFC1311900). Declaration of Interests: The authors declare: "None."Ethics Approval Statement: The study was approved by the Institutional Review Board of Guangzhou Medical University (Ethics Committee of the First Affiliated Hospital (GZMC2009-08-1336)) and adhered to the Declaration of Helsinki as previously described.

ZC3H13 promotes ITGA6 m 6 A modification for chronic obstructive pulmonary disease progression

ZC3H13 Promotes ITGA6 M6a Modification for Chronic Obstructive Pulmonary Disease Progression

m6A methyltransferase ZC3H13 improves pulmonary fibrosis in mice through regulating Bax expression

N6-methyladenosine-methylomic landscape of lung tissues of mice with chronic obstructive pulmonary disease

METTL3-mediated M6a Modification of ZBTB4 Mrna is Involved in the Smoking-Induced EMT in Cancer of the Lung.

WNT/β-catenin Signaling Regulates Cigarette Smoke-Induced Airway Inflammation Via the PPARδ/p38 Pathway

RETRACTED: METTL3-mediatedm6Amodification Ofzbtb4mrna is Involved in the Smoking-Induced EMT in Cancer of the Lung (retracted Article)

m6A RNA methylation regulators could contribute to the occurrence of chronic obstructive pulmonary disease

Late-Breaking Abstract: Mir-877 and Its Target Protein Hdac6 Are Involved in Airway Inflammation

XIST promotes apoptosis and the inflammatory response in CSE-stimulated cells via the miR-200c-3p/EGR3 axis

GLUT3 mediated airway remodeling in chronic obstructive pulmonary disease through the NF-kB/ZEB1 pathway

MicroRNA-377-3p exacerbates chronic obstructive pulmonary disease through suppressing ZFP36L1 expression and inducing lung fibroblast senescence

A Functional Mutation in Rs2664370 (T > C) in the 3'UTR of MMP16 Decreases the Risk of COPD Through Interactions with Mir-576-5p: A Family and Population Based Study

Modulating the m6A Modified Transcription Factor GATA6 Impacts Epithelial Cytokines in Acute Lung Injury

LINC00612/miR-31-5p/Notch1 Axis Regulates Apoptosis, Inflammation, and Oxidative Stress in Human Pulmonary Microvascular Endothelial Cells Induced by Cigarette Smoke Extract

[Down-regulation of HMGB1 expression ameliorates the progression of COPD in mice by inhibiting inflammatory response and epithelial mesenchymal transition]

PM2.5 induces pulmonary microvascular injury in COPD via METTL16-mediated m6A modification

Associative analysis of multi-omics data indicates that acetylation modification is widely involved in cigarette smoke-induced chronic obstructive pulmonary disease

Genetic Screening of MMP1 As a Potential Pathogenic Gene in Chronic Obstructive Pulmonary Disease

m6A modification regulates lung fibroblast-to-myofibroblast transition through modulating KCNH6 mRNA translation

HDAC6-selective inhibitor CAY10603 ameliorates cigarette smoke-induced small airway remodeling by regulating epithelial barrier dysfunction and reversing